PNC Financial Services Group
LFCR icon

PNC Financial Services Group’s Lifecore Biomedical LFCR Stock Holding History

PNC Financial Services Group’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Buy
2,060
+1,025
+99% +$5.16K ﹤0.01% 4048
2026
Q1 		$3.85K Buy
1,035
+374
+57% +$2.58K ﹤0.01% 4379
2025
Q4 		$5.41K Buy
661
+400
+153% +$2.96K ﹤0.01% 4204
2025
Q3 		$1.92K Buy
261
+9
+4% +$68 ﹤0.01% 4508
2025
Q2 		$2.05K Sell
252
-179
-42% -$1.21K ﹤0.01% 4401
2025
Q1 		$3.03K Buy
431
+192
+80% +$1.19K ﹤0.01% 4226
2024
Q4 		$1.78K Hold
239
– – ﹤0.01% 4312
2024
Q3 		$1.18K Hold
239
– – ﹤0.01% 4409
2024
Q2 		$1.23K Hold
239
– – ﹤0.01% 4384
2024
Q1 		$1.27K Hold
239
– – ﹤0.01% 4313
2023
Q4 		$1.48K Hold
239
– – ﹤0.01% 4239
2023
Q3 		$1.8K Hold
239
– – ﹤0.01% 4272
2023
Q2 		$2.31K Hold
239
– – ﹤0.01% 4339
2023
Q1 		$902 Buy
239
+130
+119% +$725 ﹤0.01% 4455
2022
Q4 		$706 Buy
+109
New +$898 ﹤0.01% 4463
2019
Q2 		– Sell
-98
Closed -$1K – 4082
2019
Q1 		$1K Hold
98
– – ﹤0.01% 3956
2018
Q4 		$1K Buy
+98
New +$1.35K ﹤0.01% 3962
2017
Q1 		– Sell
-58
Closed -$1K – 4160
2016
Q4 		$1K Buy
+58
New +$804 ﹤0.01% 3926
2016
Q3 		– Sell
-83
Closed -$1K – 4137
2016
Q2 		$1K Sell
83
-135
-62% -$1.49K ﹤0.01% 4358
2016
Q1 		$2K Buy
218
+8
+4% +$88 ﹤0.01% 4191
2015
Q4 		$2K Hold
210
– – ﹤0.01% 4172
2015
Q3 		$2K Buy
210
+7
+3% +$93 ﹤0.01% 4285
2015
Q2 		$3K Buy
203
+92
+83% +$1.33K ﹤0.01% 4270
2015
Q1 		$2K Hold
111
– – ﹤0.01% 4306
2014
Q4 		$2K Buy
111
+1
+0.9% +$13 ﹤0.01% 3803
2014
Q3 		$1K Hold
110
– – ﹤0.01% 3836
2014
Q2 		$1K Hold
110
– – ﹤0.01% 3690
2014
Q1 		$1K Buy
+110
New +$1.21K ﹤0.01% 3688
2013
Q4 		– Sell
-970
Closed -$12K – 3474
2013
Q3 		$12K Sell
970
-82
-8% -$1.14K ﹤0.01% 3180
2013
Q2 		$14K Buy
+1,052
New +$14.5K ﹤0.01% 2921

Other funds holding LFCR

WC
Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
QOP
Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

PNC Financial Services Group's LFCR Position: Q2 2026 in Review

PNC Financial Services Group increased its Lifecore Biomedical (LFCR) stake by 99% in Q2 2026, buying an estimated $5.16K and bringing the position to 2,060 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4048.

PNC Financial Services Group first reported a position in LFCR in Q2 2013 and has held it in 30 quarters since. The position peaked at $14K in Q2 2013. 98 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

  • PNC Financial Services Group held 2,060 shares of Lifecore Biomedical worth $10.8K as of Q2 2026.
  • PNC Financial Services Group bought 1,025 Lifecore Biomedical shares in Q2 2026, an estimated $5.16K.
  • Lifecore Biomedical made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4048 holding.
  • PNC Financial Services Group first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 30 quarters since.
  • PNC Financial Services Group's Lifecore Biomedical position peaked at $14K in Q2 2013.
  • 98 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.